Future Acne Therapy MSC Secretome as an Antimicrobial Agent: Literature Review
DOI:
10.29303/jbt.v25i4a.10622Published:
2025-12-09Downloads
Abstract
Acne vulgaris is a chronic inflammatory skin condition influenced by excess sebum production, bacterial colonization, and host immune responses. Microorganisms, particularly Cutibacterium acnes and Staphylococcus aureus, play a key role in acne pathogenesis and contribute to persistent inflammation. With increasing antibiotic resistance, innovative therapeutic approaches that are effective, safe, and immunomodulatory are urgently required. This literature review aims to evaluate the role of adipose-derived mesenchymal stem cell (ADMSC) secretome in inhibiting acne-causing bacteria. The review was conducted using databases including ResearchGate, PubMed, Google Scholar, and ScienceDirect, using keywords such as secretome, MSC secretome, antibacterial, C. acnes, S. aureus, and acne vulgaris. A total of 13 relevant research articles were identified. The ADMSC secretome contains antimicrobial peptides (e.g., LL-37), cytokines, growth factors, and extracellular vesicles that can disrupt bacterial membranes, enhance phagocytosis, and inhibit biofilm formation. Several studies demonstrate strong inhibitory effects against S. aureus, including resistant strains, while data on C. acnes remains limited but still supports its therapeutic relevance.
Keywords:
ADMSC secretome, LL-37, antimicrobial, Cutibacterium acnes, Staphylococcus aureusReferences
Ali, L., et al. (2025). A systematic review of preclinical studies on therapeutic potential of mesenchymal stem/stromal cells and their secretome in bacterial infections. FASEB Journal, 39.
Bhattacharjya, S., & Straus, R. (2024). Cathelicidin LL-37: Structure, mechanism, and clinical relevance. Biomolecules, 14, 223.
Castro Ramos, A. C., et al. (2024). Antibacterial effects of human mesenchymal stem cells and their derivatives: A systematic review. Frontiers in Microbiology, 15.
Cros, M. P., et al. (2023). Extracellular vesicles of Cutibacterium acnes modulate inflammatory response in skin cells. Frontiers in Cellular and Infection Microbiology, 13.
Da Silva, K., et al. (2025). Comparative analysis of secretome from diverse MSC sources for skin regeneration. Stem Cell Reviews.
Das, S., & Reynolds, R. V. (2014). Recent advances in acne pathogenesis: Implications for therapy. American Journal of Clinical Dermatology, 15(6), 479–488.
Di Francesco, A. M., et al. (2025). Cutibacterium acnes: Updates on the pathophysiology of acne and beyond. International Journal of Molecular Sciences, 26(2), 1156.
Giannasi, C., et al. (2024). Unlocking the therapeutic potential of adipose-derived stem cell secretome: A composition-based perspective. Biology, 13(12), 1–22.
Hamann, T., et al. (2025). Intraspecies diversity of Cutibacterium acnes and disease relevance. Microorganisms, 13(1), 1–14.
Jafar, H., et al. (2025). Adipose-derived mesenchymal stromal cell secretome: Mechanisms and therapeutic applications. BMC Reviews.
Jędrowiak, M., & Michalski, K. (2022). Acne vulgaris—Novel treatment options and factors affecting therapy adherence: A narrative review. Journal of Clinical Medicine, 11(24), 7535.
Kudinov, V. A., et al. (2021). Antimicrobial and regenerative effects of placental MSC secretome-based chitosan gel on infected burns. Pharmaceuticals, 14(8), 789.
Layton, A. M. (2025). Acne treatment review and present perspectives. European Medical Journal.
Maguire, G. (2019). The safe and efficacious use of secretome from fibroblasts and adipose-derived (but not bone marrow-derived) mesenchymal stem cells for skin therapeutics. Journal of Clinical and Aesthetic Dermatology, 12(8), e57–e69.
Mastrofrancesco, A., et al. (2025). Exploring acne treatments: From pathophysiological mechanisms to emerging therapies. International Journal of Molecular Sciences, 25(10), 5302.
Rajesh, A., et al. (2024). Mesenchymal stromal cell secretome enhances tissue repair and innate defense: A review. Bioengineering Reviews.
Salgado, E., et al. (2024). The hidden power of the secretome: Therapeutic potential on wound healing and cell-free regenerative medicine—A systematic review. International Journal of Molecular Sciences, 25(5), 1926.
Shaaban, F., et al. (2025). Antimicrobial activity of adipose-derived mesenchymal stromal cell secretome against methicillin-resistant Staphylococcus aureus. Stem Cell Research & Therapy, 16.
Trigo, C. M., et al. (2025). Optimization and therapeutic potential of MSC secretome in clinical translation. Regenerative Medicine Review.
Voronko, O. E., et al. (2025). LL-37 as an antimicrobial and immunomodulatory peptide: Focus on MSC secretion. Biomedicines, 13(4).
Wang, J., et al. (2024). Umbilical cord-derived mesenchymal stem cell secretome promotes skin regeneration and rejuvenation: From mechanism to therapeutics. ResearchGate.
Wu, X., et al. (2022). Mesenchymal stem cell-derived exosome therapy of microbial diseases. Frontiers in Microbiology, 13, 978807.
Żmuda, B., et al. (2024). Acne vulgaris—Review on pathogenesis and treatment. ResearchGate.
License
Copyright (c) 2025 Monica Indiasti Putri, Marlina, Ikhwan Resmala Sudji
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
